Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease lupus
Phenotype C0235618|proliferative glomerulonephritis
Sentences 5
PubMedID- 25632350 Our data support april as a candidate biomarker of renal disease activity in lupus patients with proliferative glomerulonephritis and point to low baseline blys levels predicting treatment response in ln, especially in pln.
PubMedID- 22162633 In addition to the aforementioned studies associating type i ifn and clinical and serological features of sle, cdna microarray analysis of gene expression in glomeruli, isolated by laser-capture microscopy from kidney biopsies of lupus patients with focal/diffuse proliferative glomerulonephritis, revealed increased expression of type i ifn-inducible genes, thus, implying a possible pathogenetic role for type i ifn in these patients [17].
PubMedID- 25017669 Diffuse segmental and pure diffuse global proliferative glomerulonephritis: different patterns of class iv lupus nephritis.
PubMedID- 21162701 Several studies point to higher creatinine, low complement levels, thrombocytopenia, anemia, hypertension, and proliferative glomerulonephritis as predictors of esrd in lupus nephritis within multi-ethnic cohorts.
PubMedID- 20132967 proliferative glomerulonephritis in lupus patients with human immunodeficiency virus infection: a difficult clinical challenge.

Page: 1